May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Positioning and stability evaluation of the Neo Vista brachytherapy system
Author Affiliations & Notes
  • K.K. Parsa
    Ophthalmology, Doheny Retina Institute, Los Angeles, CA
  • E. de Jaun, Jr.
    Ophthalmology, Doheny Retina Institute, Los Angeles, CA
  • Footnotes
    Commercial Relationships  K.K. Parsa, None; E. de Juan Jr., AEA Technology QSA, GmbH, Germany C.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 5137. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K.K. Parsa, E. de Jaun, Jr.; Positioning and stability evaluation of the Neo Vista brachytherapy system . Invest. Ophthalmol. Vis. Sci. 2004;45(13):5137.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:The NeoVista Brachytherapy system is a new instrument designed for treatment of choroidal neovascular membrane in diseases such as Age related macular degeneration. This instrument uses a subretinal approach to deliver localized radiation to the diseased area and thus limiting the amount of radiation exposure of non–diseased retina. This subretinal approach requires the instrument to be placed approximately 1.5 mm from the target area to deliver the prescribed dosage of radiation. Controlling the distance between the target area and the radiation source is critical for ensuring delivery of prescribed dose to the target area. The pupose of this experiment is to evaluate the positioning and stability of the NeoVista Brachytherapy system to ensure accurate delivery of prescribed radiation in a simulated environment. Methods:Using an eye model to simulate the operative environment, three retinal surgeons used the Neo Vista Brachytherapy system to perform three procedures each. The surgeons held the device in the treatment position for the duration of the treatment. Radiochromic film was used to evaluate the stability and positioning of the instrument. The results from all three surgeons were averaged to obtain the maximum and minimum mean dose rate within 2.5 mm circle (treatment area) on the radiochromic film. The results were compared to the baseline testing results normalized to the proposed treatment dose of 25Gy. Results:The maximum mean dose rate within 2.5 mm circle for all surgeons was 26.13 Gy. And the minimum mean dose rate within 2.5 mm circle for all surgeons was 18.89. The standard deviation was 2.21 and the standard deviation percent of 9.9%. Conclusions:Based on our experiment the Neo Vista Brachytherapy system positioning and stability is adequate enough to ensure accurate delivery of prescribed radiation in a simulated use environment.

Keywords: age–related macular degeneration • choroid: neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×